Drug Type Small molecule drug |
Synonyms Cefminox, Cefminox Sodium, Cefminox sodium hydrate (JP17) + [7] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (30 Jun 1987), |
Regulation- |
Molecular FormulaC16H35N7NaO14S3 |
InChIKeyRHAMUDWZLLKZNK-CVQRGOFGSA-N |
CAS Registry1351813-81-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01909 | Cefminox Sodium Hydrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Bronchitis | Japan | 30 Jun 1987 | |
Adnexal Diseases | Japan | 30 Jun 1987 | |
Bacterial Infections | Japan | 30 Jun 1987 | |
Cholecystitis | Japan | 30 Jun 1987 | |
Cystitis | Japan | 30 Jun 1987 | |
Hemorrhagic Septicemia | Japan | 30 Jun 1987 | |
Intrauterine infection | Japan | 30 Jun 1987 | |
Lung Abscess | Japan | 30 Jun 1987 | |
Peritonitis | Japan | 30 Jun 1987 | |
Pneumonia | Japan | 30 Jun 1987 | |
Pyelonephritis | Japan | 30 Jun 1987 | |
respiratory tract; infection, chronic | Japan | 30 Jun 1987 | |
Tonsillitis | Japan | 30 Jun 1987 |